SITAGLIPTIN TEVA 100 MG TBL FLM 28 I
Rychlý přehled
| Dosage form | Tablets film-coated |
|---|---|
| Výdej | Ne, lék nelze získat bez receptu. |
| Úhrada / doplatek / cena | Ano, podmínky úhrady (vykazovací limit) ale nebyl stanoven. Maximální doplatek: 805,81 Kč. Maximální cena: 1 048,56 Kč. |
| Kdo může předepsat | Prescription is not conditional on a medical specialization. |
| Složení | Sitagliptin-malát (132,92 mg), sitagliptin (100 mg), mikrokrystalická celulosa, hydrogenfosforečnan vápenatý, sodná sůl kroskarmelosy, magnesium-stearát, částečně hydrolyzovaný polyvinylalkohol, makrogol 3350, oxid tita… |
| Dostupnost / výpadek | Obnoveno The latest report from the manufacturer is from 17. 2. 2026. Výroba je obnovena od 5. 2. 2026. |
| Kód SÚKL | 0103935 |
What is the maximum co-payment for SITAGLIPTIN TEVA?
If the insurance company contributes, the maximum co-payment is 805,81 Kč. The maximum pharmacy price is 1 048,56 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.
Does the medicine have reimbursement from public health insurance?
Yes, but the reimbursement conditions (reporting limit) have not been set.
Does SITAGLIPTIN TEVA have a counted co-payment set?
No, this medicine has no counted co-payment.
How much does the insurance company pay for one dispensed reimbursed pack?
242,75 Kč.
Does the insurance company pay a higher amount in some cases?
No, the medicine has no increased reimbursement.
Does the medicine have an indication restriction?
Is it available without a medical prescription?
No, the medicine cannot be obtained without a prescription.
Which medical specialist may prescribe SITAGLIPTIN TEVA?
Prescription is not conditional on a medical specialization.
What is the composition of SITAGLIPTIN TEVA?
Sitagliptin-malát (132,92 mg), sitagliptin (100 mg), mikrokrystalická celulosa, hydrogenfosforečnan vápenatý, sodná sůl kroskarmelosy, magnesium-stearát, částečně hydrolyzovaný polyvinylalkohol, makrogol 3350, oxid titaničitý, ointmentek, žlutý oxid železitý, červený oxid železitý. More information about the composition can be found in the SPC, section 6.1.
Where can I find information about correct use of the medicine?
Which medicines are similar to SITAGLIPTIN TEVA?
The medicine belongs to ATC group A10BH01 – . Medicines with the same active substance can be found here.
Who manufactures SITAGLIPTIN TEVA?
TEVA PHARMACEUTICALS CR S.R.O., PRAHA (CZ)
Is the medicine in shortage?
The latest report from the manufacturer is from 17. 2. 2026. Production has been resumed as of 5. 2. 2026.
What is the unique code for SITAGLIPTIN TEVA?
The medicine has code 0103935. Code details can be found here.
How many packs of SITAGLIPTIN TEVA were previously dispensed on prescriptions in Czechia?
Show prescription medicine consumption
How many packs of SITAGLIPTIN TEVA were previously dispensed on request forms in Czechia?
Show request-form medicine consumption
Z čeho se skládá maximální cena léku?
The page was last updated on 17. 07. 2026